Newsfeeds - Spark Newswire

5 minute read

Eiger Biopharmaceuticals Enters Into $75M Term Loan Agreement And $5M Stock Purchase Agreement

Today, 8:33 PM

Eiger BioPharmaceuticals Enters into $75M Term Loan Agreement and $5M Stock Purchase Agreement with Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Position Ahead of Key

EIGR

1 minute read

EMA’s Advisory Committee Recommends Eiger’s Zokinvy In Premature Aging Disorder

By Vandana Singh

Today, 8:33 PM

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending Eiger…

EIGR

30 minute read

Earnings Scheduled For May 5, 2022

By Benzinga Insights

Today, 8:33 PM

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

AAOI

4 minute read

Eiger Announces Publication Of Phase 2 Results Of Avexitide In Children With Congenital Hyperinsulinism And Initiation Of Phase 3 Program

By Bill Haddad

Today, 8:33 PM

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases,

EIGR

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:33 PM

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co.

AKAN

2 minute read

31 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 8:33 PM

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results.

AKAN

3 minute read

Mid-Morning Market Update: Markets Edge higher; US Weekly Jobless Claims Drop To 214,000

By Lisa Levin

Today, 8:33 PM

U.S. stocks traded slightly higher this morning following the release of weekly jobless claims data on Thursday.

AKAN

1 minute read

Why Eiger BioPharmaceuticals Stock Is Jumping Today

By Vandana Singh

Today, 8:33 PM

Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced data from the Phase 3 TOGETHER study evaluating Peginterferon Lambda in non-hospitalized COVID-19 adult patients at high risk of progressing to severe illness.

BMY